Evidence map›Paper›PMID 36807586›Full record

ArticleScientific reports2023

SARS-CoV-2 alters neural synchronies in the brain with more severe effects in younger individuals.

Helen Valsamis, Samah Abdul Baki, Jason Leung, Samer Ghosn, Brittany Lapin, Geetha Chari, Izad-Yar Rasheed, Jaehan Park, Vineet Punia, Ghinwa Masri and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Helen ValsamisKings County Hospital, Brooklyn, NY, USA.
Samah Abdul BakiBio-Signal Group Corp, Acton, MA, USA.
Jason LeungCleveland Clinic Foundation, Cleveland, OH, USA.
Samer GhosnCleveland Clinic Foundation, Cleveland, OH, USA.
Brittany LapinCleveland Clinic Foundation, Cleveland, OH, USA.
Geetha ChariKings County Hospital, Brooklyn, NY, USA.
Izad-Yar RasheedKings County Hospital, Brooklyn, NY, USA.
Jaehan ParkKings County Hospital, Brooklyn, NY, USA.
Vineet PuniaCleveland Clinic Foundation, Cleveland, OH, USA.
Ghinwa MasriAmerican University of Sharjah, Sharjah, UAE.
Dileep NairCleveland Clinic Foundation, Cleveland, OH, USA.
Ann Marie KanieckiCleveland Clinic Foundation, Cleveland, OH, USA.
Muhammad EdhiCleveland Clinic Foundation, Cleveland, OH, USA.
Carl Y SaabCleveland Clinic Foundation, Cleveland, OH, USA. SAABC@ccf.org.
Cleveland Clinic · USKings County Hospital Center · USAmerican University of Sharjah · AEBio Signal Group (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease secondary to infection by SARS-CoV-2 (COVID19 or C19) causes respiratory illness, as well as severe neurological symptoms that have not been fully characterized. In a previous study, we developed a computational pipeline for the automated, rapid, high-throughput and objective analysis of electroencephalography (EEG) rhythms. In this retrospective study, we used this pipeline to define the quantitative EEG changes in patients with a PCR-positive diagnosis of C19 (n = 31) in the intensive care unit (ICU) of Cleveland Clinic, compared to a group of age-matched PCR-negative (n = 38) control patients in the same ICU setting. Qualitative assessment of EEG by two independent teams of electroencephalographers confirmed prior reports with regards to the high prevalence of diffuse encephalopathy in C19 patients, although the diagnosis of encephalopathy was inconsistent between teams. Quantitative analysis of EEG showed distinct slowing of brain rhythms in C19 patients compared to control (enhanced delta power and attenuated alpha-beta power). Surprisingly, these C19-related changes in EEG power were more prominent in patients below age 70. Moreover, machine learning algorithms showed consistently higher accuracy in the binary classification of patients as C19 versus control using EEG power for subjects below age 70 compared to older ones, providing further evidence for the more severe impact of SARS-CoV-2 on brain rhythms in younger individuals irrespective of PCR diagnosis or symptomatology, and raising concerns over potential long-term effects of C19 on brain physiology in the adult population and the utility of EEG monitoring in C19 patients.

Indexed as

Brain DiseasesCOVID-19AdultAgedBrainElectroencephalographyHumansRetrospective StudiesSARS-CoV-2

Identifiers

PMID36807586
PMCPMC9940054
OpenAlexW4321372932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.